We found that CXCR4 was markedly decreased in naïve mice or the increased CXCR4 was reversed in pSNL-induced neuropathic pain mice 2 days after intrathecal injection of CXCR4-siRNA (data not shown). This evidence concerns the gene CXCR4 and neuropathic pain.